Back |
home / stock / adro / adro message board
Subject | By | Source | When |
---|---|---|---|
SHORT $ADRO $3.15 ;-) | @LiftedCapital | investorshub | 12/19/2018 2:41:54 PM |
Here is another http://www.codiakbio.com/press-releases/codiak-biosciences-prese | jondoeuk | investorshub | 12/06/2018 1:06:35 AM |
In one interview Dr. Jaffee said a pilot | jondoeuk | investorshub | 12/05/2018 9:06:33 PM |
Dr. Luke presented data on $BMY's STING agonist | jondoeuk | investorshub | 12/02/2018 9:50:00 PM |
Most had failed a number of lines of | jondoeuk | investorshub | 11/15/2018 7:08:57 PM |
what about the 35 out of 41 (85%) | XXSPOWER | investorshub | 11/08/2018 7:28:12 PM |
SITC abstract https://pbs.twimg.com/media/DrUnGSyXcAA6Wvh.jpg | jondoeuk | investorshub | 11/06/2018 11:11:31 PM |
It should activate the pathway in multiple cells | jondoeuk | investorshub | 11/06/2018 11:09:41 PM |
Does $ADRO's STING stimulate the same immune cells | Murph1953 | investorshub | 10/03/2018 8:41:30 PM |
Personalised LADD won't be moving forward after the | jondoeuk | investorshub | 10/02/2018 7:54:17 PM |
$JNJ has terminated the exclusive global license agreement | jondoeuk | investorshub | 10/02/2018 3:50:43 PM |
I will no longer buy Advaxis common stock | CATTDOGG12347 | investorshub | 10/02/2018 1:50:33 PM |
News, Short Squeeze, Breakout and More Instantly...
Aduro Biotech Inc. Company Name:
ADRO Stock Symbol:
NASDAQ Market:
The 15th Annual Global CSR & ESG Awards Honours 2023 Winners DA NANG, VIETNAM, Aug 30, 2023 - (ACN Newswire) - The 15th Annual Global CSR & ESG Summit & Awards ended on a high note before a full house in Da Nang, Vietnam, on August 28. Organized at the Novotel Danang Pre...
Combined Company Will H ave Over $275 Million in Operating Capital and Trade on Nasdaq under the Ticker Symbol “KDNY” VANCOUVER, British Columbia and SEATTLE, Oct. 05, 2020 (GLOBE NEWSWIRE) -- Chinook Therap...
One-for-Five Reverse Stock Split to be Effective October 2, 2020 BERKELEY, Calif., Oct. 01, 2020 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADURO), a clinical-stage biopharmaceutical company focused on developing therapies targeting the Stimulator of Interferon Genes (ST...